Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 331 followers
Latest posts
Last updated about 11 hours ago
iRegene Hits Dual Global Firsts: U.S. Patient Dosed in Phase IIa for NouvNeu001 in Parkinson’s and First Enrollment in China’s Randomized MSA Trial for NouvNeu004
about 11 hours ago
Breaking ground: iRegene’s NouvNeu001 hits first U.S. dosing in Parkinson’s Phase IIa...
Ionis scraps early candidate for Alzheimer’s in people with Down syndrome
about 14 hours ago
Ionis Pharmaceuticals has pulled the plug on an early investigational treatment for...
Supreme Court steps in: Trump's emergency tariffs thrown out
about 16 hours ago
After the pharmaceutical industry spent much of the past year safeguarding their...
Biohaven charts comeback path after FDA blow, placing bets on obesity
about 17 hours ago
After an FDA rejection of its spinocerebellar ataxia therapy, Biohaven was forced...
Chutes & Ladders—Roche taps Aussie oncologist to lead early research
about 19 hours ago
The Swiss drugmaker has plucked an experienced scientist from Down Under to...
Mainz Biomed looks to shed ColoAlert, shifts focus in US
about 20 hours ago
Mainz Biomed, maker of the ColoAlert test, inked a private placement deal...
Grail stock craters as key NHS-Galleri trial fails to hit primary endpoint
about 20 hours ago
Grail’s shares plummeted more than 45% after-hours Thursday as the medtech revealed...
Daiichi picks former Novartis CMO John Tsai to head up R&D
about 22 hours ago
Four years after he resigned as Chief Medical Officer at Novartis in...
Candel glows brighter with $100M RTW royalty deal to fund prostate cancer drug’s launch
about 22 hours ago
As Candel Therapeutics gears up for a planned U.S. approval push for...
Novartis winds down ph. 1 solid tumor program due to lack of efficacy
1 day ago
Novartis has jettisoned an anti-cancer protein from its pipeline after the molecule...
Assessing Myelin Formation and Therapeutic Response Using 3D Organoids
1 day ago
Demyelinating diseases, including multiple sclerosis (MS) and Charcot-Marie-Tooth (CMT) disease, present a...
White House frustration may have fueled FDA’s Moderna walk back: Politico
1 day ago
Politico has reported that the White House isn’t happy with the FDA’s...